BENSALEM, Pa. -- (Business Wire)

Law Offices of Howard G. Smith announces an investigation on behalf of investors of TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE: TRXC) concerning the Company and its officers’ possible violations of federal securities laws.

On April 20, 2016, TransEnterix disclosed that its SurgiBot™ System failed to meet the United States Food and Drug Administration’s standards for substantial equivalence based upon the data and information TransEnterix submitted in its 510(k) filing.

On this news, shares of TransEnterix fell over 52% to close at just $2.27 per share on April 21, 2016.

If you purchased TransEnterix securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by e-mail to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006530/en/

Contacts:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Source: Law Offices of Howard G. Smith